Location History:
- Paris Cedex, FR (2013)
- Paris, FR (2017)
Company Filing History:
2 out of 1,744 
1 out of 20 Years Active: 2013-2017
Title: Innovator Profile: Anne Gompel – Pioneering Breast Cancer Treatment
Introduction: Anne Gompel, an accomplished inventor based in Paris, France, has made significant strides in the field of breast cancer research. With two patented inventions to her name, she has dedicated her career to developing innovative treatments aimed at improving patient outcomes in oncology. Her work reflects a strong commitment to advancing medical science and enhancing the lives of patients.
Latest Patents: Anne Gompel's latest innovations include two notable patents. The first patent focuses on "Ulipristal acetate for prevention and treatment of breast tumors." This invention pertains to utilizing ulipristal acetate, or its metabolites, for preventing or treating breast tumors, particularly in patients with a BRCA1 gene mutation. The second patent, titled "Methods for treating breast cancer with inhibitors of neurotensin activation of NTSR1," outlines methods for treating breast cancer, assessing prognosis, and detecting the disease. These patents underscore her dedication to addressing critical challenges in breast cancer treatment.
Career Highlights: Throughout her career, Anne has collaborated with premier research institutions and companies. Notably, she has worked with the Institut National de la Santé et de la Recherche Médicale, where she contributed to significant research endeavors. Additionally, she has been involved with Laboratoire HRA-Pharma, further demonstrating her commitment to advancing healthcare solutions.
Collaborations: Collaboration has been a cornerstone of Anne Gompel's professional journey. She has partnered with esteemed colleagues, including Patricia Forgez and Michele Resche-Rigon. Their combined expertise has helped propel the development of innovative therapies in the field of breast cancer research.
Conclusion: Anne Gompel stands out as a leading inventor in the domain of breast cancer treatment, with significant contributions reflected in her patents. Her work not only represents technological advancements but also embodies a heartfelt commitment to patient care. As she continues her research, the medical community eagerly anticipates the impact of her innovations on cancer treatment and patient outcomes.